ieso US company profile

At ieso, AI is in our DNA. We began using AI over a decade ago to decode patterns in mental health and improve therapy with our NHS partners in the UK. Now, we’ve brought our expertise to the U.S. with Velora, our generative AI-powered software that supports people with symptoms of anxiety and depression. Developed by our expert clinical and AI teams, Velora integrates seamlessly via API or white-lable web app into clinical workflows and care platforms to deliver safe, personalized care that works. Velora is: 🔹 Built on over 750,000 hours of human-delivered therapy, not a generic LLM. 🔹 Clinically guided and human-reviewed, not a black box. 🔹 Proven to deliver outcomes on par with human-delivered care. 🔹 Ready to deploy, allowing digital health companies to offer immediate access to mental health support, at a fraction of traditional costs. Our groundbreaking research has been published in JMIR, JAMA Psychiatry, Nature Mental Health, and Psychological Medicine and featured by TechCrunch, The New Yorker, TED, and MIT Technology Review. In 2024, Newsweek recognized us as one of the World’s Best Digital Health Companies. 🔗 Learn more: www.ieso.ai 📖 Read our latest preprint: https://osf.io/preprints/psyarxiv/8kvm6_v1 📖 Read our peer-reviewed research in JMIR: https://www.jmir.org/2025/1/e69351